3E0H805Introduction of Other Antineoplastic into Lower GI, Via Natural or Artificial Opening Endoscopic

Administration›Physiological Systems and Anatomical Regions›Introduction
  • Billable / Specific Code
ICD-10-PCS 3E0H805
CMS Source: FY 2026 ICD-10-PCS dataset. Effective Oct 1, 2025 – Sep 30, 2026.FacebookXLinkedInPrint

3E0H805 is a billable ICD-10-PCS procedure code for Introduction of Other Antineoplastic into Lower GI, Via Natural or Artificial Opening Endoscopic. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The root operation Introduction involves putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products. In AHRQ's Clinical Classifications Software (CCSR), this procedure falls under Chemotherapy.

Code Identity

ICD-10-PCS Code
3E0H805
Billable Status
Yes — Valid for Submission
Code Describes
Introduction of Other Antineoplastic into Lower GI, Via Natural or Artificial Opening Endoscopic
Short Description
Introduction of Other Antineoplastic into Lower GI, Endo
Parent Code
3E0

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

PositionDesignationValueMeaning
1Section3Administration
2Body SystemEPhysiological Systems and Anatomical Regions
3Operation0Introduction
4BodySystem/RegionHLower GI
5Approach8Via Natural or Artificial Opening Endoscopic
6Substance0Antineoplastic
7Qualifier5Other Antineoplastic

In the ICD-10-PCS Alphabetic Index

These FY 2026 ICD-10-PCS Alphabetic Index entries lead to this code:

TECENTRIQ(R)
Anatomy or device term that leads here
Blinatumomab
Anatomy or device term that leads here
Gilteritinib
Anatomy or device term that leads here
Proctoclysis
Leads to this code's table
XOSPATA(R) (Gilteritinib)
Anatomy or device term that leads here
BLINCYTO(R) (blinatumomab)
Anatomy or device term that leads here
Apalutamide Antineoplastic
Anatomy or device term that leads here
Erdafitinib Antineoplastic
Anatomy or device term that leads here
Venetoclax Antineoplastic (tablets)
Anatomy or device term that leads here
ERLEADA(tm) (Apalutamide Antineoplastic)
Anatomy or device term that leads here
Balversa(tm) (Erdafitinib Antineoplastic)
Anatomy or device term that leads here
Venclexta(R) (Venetoclax Antineoplastic tablets)
Anatomy or device term that leads here
Introduction of substance in or on, Gastrointestinal Tract, Lower
Leads to this code's table
Introduction of substance in or on, Gastrointestinal Tract, Lower, Gas
Leads to this code's table
Introduction of substance in or on, Gastrointestinal Tract, Lower, Hypnotics
Leads to this code's table

Browse the full ICD-10-PCS Alphabetic Index →

Clinical Classification (CCSR)

AHRQ groups this procedure code into these clinical categories.

ADM012
Chemotherapy
Clinical domain: Administration of Therapeutic Substances

Convert to ICD-9-PCS

Closest ICD-9-PCS equivalents for this code under the General Equivalence Mappings.

00.10
Implantation of chemotherapeutic agent
Approximate match.

Similar Procedure Codes

Questions About 3E0H805

Is 3E0H805 a billable code?

Yes. This is a complete seven-character ICD-10-PCS code, specific enough to report Introduction of Other Antineoplastic into Lower GI, Via Natural or Artificial Opening Endoscopic on inpatient claims from October 1, 2025 through September 30, 2026.

What do the characters in 3E0H805 mean?

The code breaks down character by character: the 1st character 3 is the Section (Administration); the 2nd character E is the Body System (Physiological Systems and Anatomical Regions); the 3rd character 0 is the Operation (Introduction); the 4th character H is the BodySystem/Region (Lower GI); the 5th character 8 is the Approach (Via Natural or Artificial Opening Endoscopic); the 6th character 0 is the Substance (Antineoplastic); the 7th character 5 is the Qualifier (Other Antineoplastic).

What is the ICD-9-PCS equivalent of 3E0H805?

Under the General Equivalence Mappings, Introduction of Other Antineoplastic into Lower GI, Via Natural or Artificial Opening Endoscopic crosswalks to ICD-9-PCS 00.10 (Implantation of chemotherapeutic agent). The mapping is approximate, so confirm it fits the documentation.